Testing The Effect Of Adding Abiraterone Acetate And Enzalutamide To Metastatic Hormone Refractory Prostate Cancer, When Compared To Enzalutamide Alon
Posted Date: May 15, 2019
- Investigator: Nilesh Patil
- Type of Study: Drug
The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone and enzalutamide with enzalutamide alone on patients and their cancer to find out which is better. Doctors are uncertain about which way is the best way to treat castration resistant prostate cancer (CRP
Criteria:
To Be Eligible To Participate, Patients Must Have Prostate Cancer That Has Spread And Has Not Respon
Keywords:
Abiraterone, Metastatic Prostate , Enzalutamide, Cancer, A031201
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu